The Venture Codex Logo

The Venture Codex

SK Biopharmaceuticals

221 Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, South Korea

Overview

Specialty pharmaceuticals and specialized manufacturing services.

Founded

2011

Deals ยท 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series D

Geographic focus

China

Sector focus

Biotechnology
Manufacturing
Therapeutics

Investment portfolio

1rounds
NAMEDATESIZE
Full-Life Technologies
May 2026Participated
$150 MSeries D
Full-Life Technologies
May 2026Participated
$150 MSeries D
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

SK Biopharmaceuticals: 1 funding rounds are recorded in the selected participation categories.All available history.
SK Biopharmaceuticals: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series C+01

Monthly Deal Activity

SK Biopharmaceuticals: 1 deals are recorded across 6 months.All available history.
SK Biopharmaceuticals: 1 deals are recorded across 6 months. All available history
MonthDeals
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

SK Biopharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

SK Biopharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1

Deal Size Distribution

SK Biopharmaceuticals: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

SK Biopharmaceuticals: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

SK Biopharmaceuticals: China has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

SK Biopharmaceuticals: China has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
China1
SK Biopharmaceuticals: 8 co-investors are shown, with Chengwei Capital sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

SK Biopharmaceuticals: 8 co-investors are shown, with Chengwei Capital sharing 1 recorded deals. All available history
Co-investorShared deals
Chengwei Capital1
Junson Capital1
Plaisance Capital Management1
Sequoia Capital1
Sky9 Capital1
TSG Capital1
Vivo Capital1
Yunion Healthcare Ventures1

Investment Strategy

SK Biopharmaceuticals: Led accounts for 0% and participating for 100% of round participation.All available history.
SK Biopharmaceuticals: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating1100%
SK Biopharmaceuticals: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
SK Biopharmaceuticals: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Yoonchung Chey

Vice President of Strategy Department